Loading…
Based on limited metadata, this Warning Letter issued to FICOSOTA LTD on February 28, 2020, concerns drug manufacturing or distribution operations. Without access to the full letter text or subject line, the specific nature of the regulatory violations cannot be determined from the available information. The FDA's action indicates concerns serious enough to warrant a formal warning, though the issuing office and complete violation details are not specified in the metadata provided. To understand the full scope and specific compliance issues, the complete Warning Letter would need to be reviewed.